106 related articles for article (PubMed ID: 24454825)
1. Role of receptor activity modifying protein 1 in function of the calcium sensing receptor in the human TT thyroid carcinoma cell line.
Desai AJ; Roberts DJ; Richards GO; Skerry TM
PLoS One; 2014; 9(1):e85237. PubMed ID: 24454825
[TBL] [Abstract][Full Text] [Related]
2. Strontium is a biased agonist of the calcium-sensing receptor in rat medullary thyroid carcinoma 6-23 cells.
Thomsen AR; Worm J; Jacobsen SE; Stahlhut M; Latta M; Bräuner-Osborne H
J Pharmacol Exp Ther; 2012 Dec; 343(3):638-49. PubMed ID: 22942242
[TBL] [Abstract][Full Text] [Related]
3. Calcium-sensing Receptor, a Potential Biomarker Revealed by Large-scale Public Databases and Experimental Verification in Metastatic Breast Cancer.
Xie W; Xu H; Cheng Y; Lin X; Zeng J; Sun Y
Technol Cancer Res Treat; 2024; 23():15330338241254219. PubMed ID: 38780484
[TBL] [Abstract][Full Text] [Related]
4. Alterations in gene expression and microbiome composition upon calcium-sensing receptor deletion in the mouse esophagus.
Abdulnour-Nakhoul SM; Kolls JK; Flemington EK; Ungerleider NA; Nakhoul HN; Song K; Nakhoul NL
Am J Physiol Gastrointest Liver Physiol; 2024 Apr; 326(4):G438-G459. PubMed ID: 38193195
[TBL] [Abstract][Full Text] [Related]
5. Expression of the Calcium-Sensing Receptor on Normal and Abnormal Parathyroid and Thyroid Tissue.
Worth AL; Ayrapetyan M; Maygarden SJ; Li Z; Wu Z; Agala CB; Kim LT
J Surg Res; 2024 Jan; 293():618-624. PubMed ID: 37837817
[TBL] [Abstract][Full Text] [Related]
6. Itch receptor MRGPRX4 interacts with the receptor activity-modifying proteins.
Kotliar IB; Ceraudo E; Kemelmakher-Liben K; Oren DA; Lorenzen E; Dodig-Crnković T; Horioka-Duplix M; Huber T; Schwenk JM; Sakmar TP
J Biol Chem; 2023 May; 299(5):104664. PubMed ID: 37003505
[TBL] [Abstract][Full Text] [Related]
7. GPCRs globally coevolved with receptor activity-modifying proteins, RAMPs.
Barbash S; Lorenzen E; Persson T; Huber T; Sakmar TP
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):12015-12020. PubMed ID: 29078385
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the structure of RAMP1 by mutagenesis and molecular modeling.
Simms J; Hay DL; Wheatley M; Poyner DR
Biophys J; 2006 Jul; 91(2):662-9. PubMed ID: 16632510
[TBL] [Abstract][Full Text] [Related]
9. RAMP1 as a novel prognostic biomarker in pan-cancer and osteosarcoma.
Xie L; Xiao W; Fang H; Liu G
PLoS One; 2023; 18(10):e0292452. PubMed ID: 37796823
[TBL] [Abstract][Full Text] [Related]
10. Whole-brain mapping of amylin-induced neuronal activity in receptor activity-modifying protein 1/3 knockout mice.
Skovbjerg G; Roostalu U; Hansen HH; Lutz TA; Le Foll C; Salinas CG; Skytte JL; Jelsing J; Vrang N; Hecksher-Sørensen J
Eur J Neurosci; 2021 Apr; ():. PubMed ID: 33905587
[TBL] [Abstract][Full Text] [Related]
11. Solid-phase extraction with the functionalization of calcium-sensing receptors onto magnetic microspheres as an affinity probe can capture ligands selectively from herbal extract.
Cheng P; Meng K; Shi X; Jiao M; Han Y; Li X; Liu P; Xiao C
Mikrochim Acta; 2023 Dec; 191(1):34. PubMed ID: 38108923
[TBL] [Abstract][Full Text] [Related]
12. Calcium sensing receptor expression and signalling in cardiovascular physiology and disease.
Schreckenberg R; Schlüter KD
Vascul Pharmacol; 2018 Mar; ():. PubMed ID: 29514057
[TBL] [Abstract][Full Text] [Related]
13. The CaSR in Pathogenesis of Breast Cancer: A New Target for Early Stage Bone Metastases.
Das S; Clézardin P; Kamel S; Brazier M; Mentaverri R
Front Oncol; 2020; 10():69. PubMed ID: 32117726
[TBL] [Abstract][Full Text] [Related]
14. Silicon-Rhodamine Functionalized Evocalcet Probes Potently and Selectively Label Calcium Sensing Receptors
Bátora D; Fischer JP; Kaderli RM; Varga M; Lochner M; Gertsch J
ACS Pharmacol Transl Sci; 2024 May; 7(5):1557-1570. PubMed ID: 38751613
[TBL] [Abstract][Full Text] [Related]
15. Editorial: The calcium-sensing receptor: from physiology to pharmacology.
Ranieri M; Schepelmann M; Valenti G; Kallay E; Riccardi D
Front Physiol; 2023; 14():1225074. PubMed ID: 37346486
[No Abstract] [Full Text] [Related]
16. Pan-cancer analysis revealed prognosis value and immunological relevance of RAMPs.
Yang S; Huan R; Deng M; Luo T; Peng S; Xiong Y; Han G; Liu J; Zhang J; Tan Y
Heliyon; 2024 Feb; 10(3):e24849. PubMed ID: 38317990
[TBL] [Abstract][Full Text] [Related]
17. Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins.
Kotliar IB; Lorenzen E; Schwenk JM; Hay DL; Sakmar TP
Pharmacol Rev; 2023 Jan; 75(1):1-34. PubMed ID: 36757898
[TBL] [Abstract][Full Text] [Related]
18. Accelerated Development With Increased Bone Mass and Skeletal Response to Loading Suggest Receptor Activity Modifying Protein-3 as a Bone Anabolic Target.
Pacharne S; Livesey M; Kadmiel M; Wang N; Caron KM; Richards GO; Skerry TM
Front Endocrinol (Lausanne); 2021; 12():807882. PubMed ID: 35095771
[TBL] [Abstract][Full Text] [Related]
19. RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors.
Pioszak AA; Hay DL
Adv Pharmacol; 2020; 88():115-141. PubMed ID: 32416865
[TBL] [Abstract][Full Text] [Related]
20. Dawn of a New RAMPage.
Serafin DS; Harris NR; Nielsen NR; Mackie DI; Caron KM
Trends Pharmacol Sci; 2020 Apr; 41(4):249-265. PubMed ID: 32115276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]